Abivax (ABVX) PT Raised to $187 at Citizens

June 2, 2026 4:04 AM

Citizens analyst Jason Butler raised the price target on Abivax (NASDAQ: ABVX) to $187.00 (from $131.00) while maintaining a Market ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found